SHUKRA PHARMACEUTICALS L Share Price

SHUKRA PHARMACEUTICALS L Share Price

NSE: SHUKRAPHAR
|
Pharmaceuticals
|
S Cap
₹ 51.93
+₹5.14 (10.99%)
1D
Last updated 03 Sep, 2026, 15:58 IST

SHUKRA PHARMACEUTICALS L Share Price Today

As of 3 Sep 2026, SHUKRA PHARMACEUTICALS L share price is ₹51.93. The stock opened at ₹47.37, compared to its previous close of ₹46.79. During today's trading session, SHUKRA PHARMACEUTICALS L share price moved in the range of ₹47.10 to ₹54.90, with an average price of ₹51.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹40.06 and a high of ₹54.90. On the performance front, SHUKRA PHARMACEUTICALS L share price has increased by 12.96% over the last six months and is up 12.96% on a year-on-year basis.

₹47.10
10.99% up today
₹54.90
1D LOW
1D HIGH

SHUKRA PHARMACEUTICALS L Returns Calculator

Circuit
L
H
₹37.44
₹56.14
52-week
L
H
₹40.06
₹54.90

About SHUKRA PHARMACEUTICALS L

SHUKRA PHARMACEUTICALS L Share Price
ISIN
INE551C01044
Sector Market Cap
₹ 2,056.96 Cr

Shukra Pharmaceuticals Limited is an India-based pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical products globally and domestically. The Company’s product portfolio consists of tablet and capsules (general) solid oral dosage form and small volume parenteral- liquid injection vial and ampules. The Company’s products include Losartan Potassium Tablets USP 50 mg, Glimepiride Tablets USP 2 mg, Pantoprazole Tablets USP 40 mg, Methocarbamol Tablets USP 500 mg, Omeprazole Capsule IP 20 mg, Amlodipine besylate Tablets USP 5 mg, Ranitidine Tablets USP 150 mg, Ranitidine Tablets USP 300 mg, Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Atorvastatin Tablets USP 10mg, Sildenafil citrate Tablets BP 100 mg, Diclofenac Sodium Tablets BP 50 mg, Mebendazole Tablets USP 100 mg, Paracetamol Tablets BP 500 mg, Artemether 80 mg and Lumefantrine 480 mg Tablets, Clotrimazole Vaginal Tablets 100 mg and others.

SHUKRA PHARMACEUTICALS L Financial Highlights

  • Revenue: SHUKRA PHARMACEUTICALS L reported revenue of ₹61.31 crore in FY26 vs ₹36.80 crore in FY25. It showed an increase of 66.60% on a yearly basis.
  • Operating Profit: SHUKRA PHARMACEUTICALS L reported an operating profit of ₹28.79 crore in FY26 vs ₹13.34 crore in FY25. It showed an increase of 115.82% on a year-on-year basis.
  • Net Profit: SHUKRA PHARMACEUTICALS L reported a net profit of ₹22.06 crore in FY26 vs ₹9.58 crore in FY25. It showed an increase of 130.27% on a yearly basis.

SHUKRA PHARMACEUTICALS L Quarterly Result Highlights

  • SHUKRA PHARMACEUTICALS L reported revenue of ₹24.06 crore in Jun 2026, compared with ₹7.27 crore in Mar 2026, representing an increase of 230.95% on a quarter-on-quarter (QoQ) basis.
  • SHUKRA PHARMACEUTICALS L reported an operating profit of ₹18.17 crore in Jun 2026, compared with ₹0.38 crore in Mar 2026, representing an increase of 4,681.58% on a quarter-on-quarter (QoQ) basis.
  • SHUKRA PHARMACEUTICALS L reported a profit of ₹12.96 crore in Jun 2026, compared with ₹1.72 crore in Mar 2026, reflecting an increase of 853.49% on a QoQ basis.
Know more
Promoters
51.15%
FII
0.00%
Other DII
0.11%
Retail and other
48.73%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Aug 20260.00%
Mkt Cap Cr
2,056.96
P/E
60.77
P/B
21.42
ROE
24.55%
D/E
0.06
ROCE
31.50%
Div. Yield
0.02%
EPS(TTM)
0.50
Turnover
0.64
EV/EBITDA
38.60
Net Margin
0.00%
Op. Margin
0.00%
ROA
28.93%
Quick Ratio
0.00
Curr. Ratio
3.94
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Shukra Pharma. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Shukra Pharma. appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Shukra Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma98,304.7047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

SHUKRA PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2026
Revenue36.861.31
Operating profit13.3428.79
Net profit9.5822.06

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹32.59₹74.57₹58.83₹20.49
Other Income₹4.21₹2.82₹1.20₹0.08
Total Revenue₹36.79₹77.39₹60.03₹20.57
Total Expenses₹23.46₹57.50₹55.59₹19.55
Profit Before Tax₹13.34₹19.88₹4.44₹1.02
Tax₹3.76₹1.35₹0.04₹0.27
Profit After Tax₹9.58₹18.54₹4.41₹0.75
EPS - Basic₹0.22₹16.93₹26.21₹4.79
EPS - Diluted₹0.22₹16.93₹26.21₹4.79

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹13.34₹19.88₹4.44₹1.02
Income before WC changes₹15.46₹21.43₹6.04₹2.93
Change in Assets-₹7.06₹2.85-₹33.27₹0.44
Change in Liabilities₹3.28-₹28.85₹30.64₹5.06
Change in WC-₹3.78-₹26.01-₹2.62₹5.50
Cash flow from Operations₹7.92-₹5.20₹3.17₹7.99
Cash flow from Investing-₹1.26-₹1.20-₹4.43-₹1.53
Cash flow from Financing-₹4.52₹12.41₹4.94-₹6.68
Total Cash Flow₹2.14₹6.01₹3.68-₹0.21
Cash (Start of the year)₹9.98₹3.97₹0.29₹0.50
Cash (End of the year)₹12.12₹9.98₹3.97₹0.29

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹21.34₹21.60₹21.89₹19.24
Current Assets₹65.43₹56.23₹53.07₹15.87
Total Assets₹86.77₹77.84₹74.97₹35.11
Current Liabilities₹17.28₹14.15₹42.51₹12.38
Net Current Asset₹48.14₹42.08₹10.57₹3.50
Non-Current Liabilities₹6.65₹6.04₹7.16₹6.39
Equity Capital₹62.84₹57.64₹25.30₹16.35
Total Equity & Liabilities₹86.77₹77.84₹74.97₹35.11
* All values are in INR Crore
Qty
Bid
968
51.93
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 968
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
1
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
ATR (14)
1.92
Neutral
STOCH(9,6)
90.3
Bearish
ADX(9)
29.77
Bearish
ROC(12)
12.91
Bullish
WillR(14)
-6.27
Bearish
Period
Simple value
Exponential vaue
5D
44.82
45.14
10D
44.38
44.77
20D
43.64
0
50D
43.64
0
100D
43.64
0
Volume trend — traded volume by day
3 Sep89L
2 Sep29L
1 Sep18L
31 Aug16L
28 Aug9L
27 Aug10L
Average28L
Compare against other stocks
SHUKRA PHARMACEUTICALS L Share Price
SHUKRA PHARMACEUTICALS L
Pharmaceuticals
Add Stock
Add Another

SHUKRA PHARMACEUTICALS L Share Price FAQs